Robust antigen specific th17 T cell response to group A Streptococcus is dependent on IL-6 and intranasal route of infection.

PubWeight™: 1.07‹?› | Rank: Top 10%

🔗 View Article (PMC 3178561)

Published in PLoS Pathog on September 22, 2011

Authors

Thamotharampillai Dileepan1, Jonathan L Linehan, James J Moon, Marion Pepper, Marc K Jenkins, Patrick P Cleary

Author Affiliations

1: Department of Microbiology, University of Minnesota, Minneapolis, Minnesota, United States of America. dile0003@umn.edu

Articles citing this

The role of naive T cell precursor frequency and recruitment in dictating immune response magnitude. J Immunol (2012) 3.20

IL-6 as a keystone cytokine in health and disease. Nat Immunol (2015) 2.14

Vaccine-induced th17 cells are maintained long-term postvaccination as a distinct and phenotypically stable memory subset. Infect Immun (2012) 1.20

Location, location, location: tissue-specific regulation of immune responses. J Leukoc Biol (2013) 0.96

Bacterial superantigens promote acute nasopharyngeal infection by Streptococcus pyogenes in a human MHC Class II-dependent manner. PLoS Pathog (2014) 0.95

Group A Streptococcus intranasal infection promotes CNS infiltration by streptococcal-specific Th17 cells. J Clin Invest (2015) 0.90

Generation of Th17 cells in response to intranasal infection requires TGF-β1 from dendritic cells and IL-6 from CD301b+ dendritic cells. Proc Natl Acad Sci U S A (2015) 0.87

Sortase A induces Th17-mediated and antibody-independent immunity to heterologous serotypes of group A streptococci. PLoS One (2014) 0.83

Responses of innate immune cells to group A Streptococcus. Front Cell Infect Microbiol (2014) 0.79

Tissue tropisms in group A Streptococcus: what virulence factors distinguish pharyngitis from impetigo strains? Curr Opin Infect Dis (2016) 0.78

Cellular and Molecular Dynamics of Th17 Differentiation and its Developmental Plasticity in the Intestinal Immune Response. Front Immunol (2017) 0.77

The frequency of naive and early-activated hapten-specific B cell subsets dictates the efficacy of a therapeutic vaccine against prescription opioid abuse. J Immunol (2015) 0.77

Identifying protective Streptococcus pyogenes vaccine antigens recognized by both B and T cells in human adults and children. Sci Rep (2016) 0.76

Dendritic cell MST1 inhibits Th17 differentiation. Nat Commun (2017) 0.75

Interleukin-17A Contributes to the Control of Streptococcus pyogenes Colonization and Inflammation of the Female Genital Tract. Sci Rep (2016) 0.75

Pediatric Autoimmune Disorders Associated with Streptococcal Infections and Tourette's Syndrome in Preclinical Studies. Front Neurosci (2016) 0.75

In Situ Peptide-MHC-II Tetramer Staining of Antigen-Specific CD4+ T Cells in Tissues. PLoS One (2015) 0.75

Novel platform technology for modular mucosal vaccine that protects against streptococcus. Sci Rep (2016) 0.75

Gut Microbial Membership Modulates CD4 T Cell Reconstitution and Function after Sepsis. J Immunol (2016) 0.75

CNS autoimmune disease after Streptococcus pyogenes infections: animal models, cellular mechanisms and genetic factors. Future Neurol (2016) 0.75

Local Th17/IgA immunity correlate with protection against intranasal infection with Streptococcus pyogenes. PLoS One (2017) 0.75

Autoimmune valvular carditis. Curr Allergy Asthma Rep (2015) 0.75

Reduced Th17 responses to Streptococcus pneumoniae in infection-prone children can be rescued by addition of innate cytokines. J Infect Dis (2017) 0.75

Hello from the Other Side: How Autoantibodies Circumvent the Blood-Brain Barrier in Autoimmune Encephalitis. Front Immunol (2017) 0.75

Articles cited by this

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature (2006) 46.36

IL-17 and Th17 Cells. Annu Rev Immunol (2009) 23.02

The global burden of group A streptococcal diseases. Lancet Infect Dis (2005) 13.58

Naive CD4(+) T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude. Immunity (2007) 9.26

Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature (1994) 8.85

Late developmental plasticity in the T helper 17 lineage. Immunity (2009) 8.81

Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med (2005) 8.49

Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity (2009) 6.24

Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med (2009) 5.55

Naive and memory CD4+ T cell survival controlled by clonal abundance. Science (2006) 4.67

Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS Pathog (2008) 4.05

Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis. Immunity (2009) 3.33

Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J Immunol (2006) 3.32

Different routes of bacterial infection induce long-lived TH1 memory cells and short-lived TH17 cells. Nat Immunol (2009) 3.19

An inverse relationship between T cell receptor affinity and antigen dose during CD4(+) T cell responses in vivo and in vitro. Proc Natl Acad Sci U S A (1999) 3.15

Tracking epitope-specific T cells. Nat Protoc (2009) 2.96

Toll-like receptor 2 signaling in CD4(+) T lymphocytes promotes T helper 17 responses and regulates the pathogenesis of autoimmune disease. Immunity (2010) 2.90

CD4+ T cells that enter the draining lymph nodes after antigen injection participate in the primary response and become central-memory cells. J Exp Med (2006) 1.97

Increased competition for antigen during priming negatively impacts the generation of memory CD4 T cells. Proc Natl Acad Sci U S A (2007) 1.71

Intracellular reservoir of Streptococcus pyogenes in vivo: a possible explanation for recurrent pharyngotonsillitis. Laryngoscope (1997) 1.67

Pathogenesis of group A streptococcal infections and their sequelae. Adv Exp Med Biol (2008) 1.64

Th17 Cells and autoimmune encephalomyelitis (EAE/MS). Allergol Int (2008) 1.54

High-frequency intracellular invasion of epithelial cells by serotype M1 group A streptococci: M1 protein-mediated invasion and cytoskeletal rearrangements. Mol Microbiol (1999) 1.48

Membranous cells in nasal-associated lymphoid tissue: a portal of entry for the respiratory mucosal pathogen group A streptococcus. J Immunol (2003) 1.45

New understanding of the group A Streptococcus pathogenesis cycle. Trends Microbiol (2007) 1.41

Th17 cells in immunity and autoimmunity. Ann Rheum Dis (2008) 1.38

Streptococcal M protein: a multipotent and powerful inducer of inflammation. J Immunol (2006) 1.36

Group A streptococci among school-aged children: clinical characteristics and the carrier state. Pediatrics (2004) 1.25

Induction of TGF-beta1 and TGF-beta1-dependent predominant Th17 differentiation by group A streptococcal infection. Proc Natl Acad Sci U S A (2010) 1.12

Molecular pathogenesis of rheumatic fever and rheumatic heart disease. Expert Rev Mol Med (2005) 1.12

Plasticity of T-cell phenotype and function: the T helper type 17 example. Immunology (2009) 1.11

Primary induction of CD4 T cell responses in nasal associated lymphoid tissue during group A streptococcal infection. Eur J Immunol (2004) 1.07

Streptococcus pyogenes: Insight into the function of the streptococcal superantigens. Int J Biochem Cell Biol (2006) 1.07

The transient nature of the Th17 phenotype. Eur J Immunol (2010) 1.04

The occurrence of hemolytic streptococci in school children in Nashville, Tennessee, 1961-1967. Am J Epidemiol (1973) 0.98

Commercial peptidoglycan preparations are contaminated with superantigen-like activity that stimulates IL-17 production. J Leukoc Biol (2007) 0.93

Endogenous interleukin-6 plays a crucial protective role in streptococcal toxic shock syndrome via suppression of tumor necrosis factor alpha production. Infect Immun (2005) 0.93

Intranasal bacteria induce Th1 but not Treg or Th2. Mucosal Immunol (2008) 0.87

The early interferon response of nasal-associated lymphoid tissue to Streptococcus pyogenes infection. FEMS Immunol Med Microbiol (2009) 0.86

Protein F1 and Streptococcus pyogenes resistance to phagocytosis. Infect Immun (2007) 0.84

Streptococcal M protein enhances TGF-beta production and increases surface IgA-positive B cells in vitro in IgA nephropathy. Nephrol Dial Transplant (2000) 0.81

M1 protein from streptococcus pyogenes induces nitric oxide-mediated vascular hyporesponsiveness to phenylephrine: involvement of toll-like receptor activation. Shock (2010) 0.79

Pharyngeal colonisation, ADNB response and development of cardiac lesions in mice following intranasal inoculation with group A beta haemolytic streptococcus M type 18. Indian J Exp Biol (1998) 0.77

Articles by these authors

Naive CD4(+) T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude. Immunity (2007) 9.26

Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity. Immunity (2003) 5.52

Naive and memory CD4+ T cell survival controlled by clonal abundance. Science (2006) 4.67

Different B cell populations mediate early and late memory during an endogenous immune response. Science (2011) 3.63

Opposing signals from the Bcl6 transcription factor and the interleukin-2 receptor generate T helper 1 central and effector memory cells. Immunity (2011) 3.58

Linked T cell receptor and cytokine signaling govern the development of the regulatory T cell repertoire. Immunity (2008) 3.56

Tracking salmonella-specific CD4 T cells in vivo reveals a local mucosal response to a disseminated infection. Immunity (2002) 3.42

The humoral immune response is initiated in lymph nodes by B cells that acquire soluble antigen directly in the follicles. Immunity (2007) 3.28

Single naive CD4+ T cells from a diverse repertoire produce different effector cell types during infection. Cell (2013) 3.22

The role of naive T cell precursor frequency and recruitment in dictating immune response magnitude. J Immunol (2012) 3.20

Different routes of bacterial infection induce long-lived TH1 memory cells and short-lived TH17 cells. Nat Immunol (2009) 3.19

Antigen presentation to naive CD4 T cells in the lymph node. Nat Immunol (2003) 3.03

Tracking epitope-specific T cells. Nat Protoc (2009) 2.96

Covalently immobilized gradients of bFGF on hydrogel scaffolds for directed cell migration. Biomaterials (2005) 2.83

Development of a novel transgenic mouse for the study of interactions between CD4 and CD8 T cells during graft rejection. Am J Transplant (2003) 2.69

Origins of CD4(+) effector and central memory T cells. Nat Immunol (2011) 2.35

Three-dimensional micropatterning of bioactive hydrogels via two-photon laser scanning photolithography for guided 3D cell migration. Biomaterials (2008) 2.23

Photolithographic patterning of polyethylene glycol hydrogels. Biomaterials (2005) 2.20

Acute gastrointestinal infection induces long-lived microbiota-specific T cell responses. Science (2012) 2.01

CD4+ T cells that enter the draining lymph nodes after antigen injection participate in the primary response and become central-memory cells. J Exp Med (2006) 1.97

Preferential accumulation of antigen-specific effector CD4 T cells at an antigen injection site involves CD62E-dependent migration but not local proliferation. J Exp Med (2003) 1.87

A germinal center-independent pathway generates unswitched memory B cells early in the primary response. J Exp Med (2012) 1.86

CXCR3 chemokine receptor-ligand interactions in the lymph node optimize CD4+ T helper 1 cell differentiation. Immunity (2012) 1.85

Distinct functions of antigen-specific CD4 T cells during murine Mycobacterium tuberculosis infection. Proc Natl Acad Sci U S A (2010) 1.85

Behavior of parasite-specific effector CD8+ T cells in the brain and visualization of a kinesis-associated system of reticular fibers. Immunity (2009) 1.84

Dendritic cell antigen presentation drives simultaneous cytokine production by effector and regulatory T cells in inflamed skin. Immunity (2009) 1.84

Therapeutic cell engineering with surface-conjugated synthetic nanoparticles. Nat Med (2010) 1.71

Visualizing the first 50 hr of the primary immune response to a soluble antigen. Immunity (2004) 1.66

Hematopoietic engraftment of human embryonic stem cell-derived cells is regulated by recipient innate immunity. Stem Cells (2006) 1.64

Covalently-immobilized vascular endothelial growth factor promotes endothelial cell tubulogenesis in poly(ethylene glycol) diacrylate hydrogels. J Biomater Sci Polym Ed (2009) 1.61

On the composition of the preimmune repertoire of T cells specific for Peptide-major histocompatibility complex ligands. Annu Rev Immunol (2010) 1.61

Transcription-induced chromatin remodeling at the c-myc gene involves the local exchange of histone H2A.Z. J Biol Chem (2005) 1.56

Quantitative impact of thymic selection on Foxp3+ and Foxp3- subsets of self-peptide/MHC class II-specific CD4+ T cells. Proc Natl Acad Sci U S A (2011) 1.54

Poly(ethylene glycol) hydrogels conjugated with a collagenase-sensitive fluorogenic substrate to visualize collagenase activity during three-dimensional cell migration. Biomaterials (2007) 1.52

Efficient transfection of embryonic and adult stem cells. Stem Cells (2004) 1.47

Efficient and stable transgene expression in human embryonic stem cells using transposon-mediated gene transfer. Stem Cells (2007) 1.44

Detection of an autoreactive T-cell population within the polyclonal repertoire that undergoes distinct autoimmune regulator (Aire)-mediated selection. Proc Natl Acad Sci U S A (2012) 1.41

Pillars article: visualization of Peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity. 1994. 1: 327-339. J Immunol (2013) 1.40

Regulation of NF-kappaB activation in T cells via association of the adapter proteins ADAP and CARMA1. Science (2007) 1.39

Visualization of the genesis and fate of isotype-switched B cells during a primary immune response. J Exp Med (2003) 1.38

Arthritogenic self-reactive CD4+ T cells acquire an FR4hiCD73hi anergic state in the presence of Foxp3+ regulatory T cells. J Immunol (2011) 1.32

Proteolytically degradable hydrogels with a fluorogenic substrate for studies of cellular proteolytic activity and migration. Biotechnol Prog (2005) 1.29

T cell receptor cross-reactivity between similar foreign and self peptides influences naive cell population size and autoimmunity. Immunity (2015) 1.29

Presentation of Toxoplasma gondii antigens via the endogenous major histocompatibility complex class I pathway in nonprofessional and professional antigen-presenting cells. Infect Immun (2007) 1.26

Heterogeneity in the differentiation and function of memory B cells. Trends Immunol (2012) 1.25

Adjuvant formulation structure and composition are critical for the development of an effective vaccine against tuberculosis. J Control Release (2013) 1.25

In situ analysis reveals physical interactions between CD11b+ dendritic cells and antigen-specific CD4 T cells after subcutaneous injection of antigen. J Immunol (2002) 1.18

Negative selection and peptide chemistry determine the size of naive foreign peptide-MHC class II-specific CD4+ T cell populations. J Immunol (2010) 1.18

In vivo antigen presentation. Curr Opin Immunol (2004) 1.18

IL-1 acts on antigen-presenting cells to enhance the in vivo proliferation of antigen-stimulated naive CD4 T cells via a CD28-dependent mechanism that does not involve increased expression of CD28 ligands. Eur J Immunol (2004) 1.18

Temporal expression of bacterial proteins instructs host CD4 T cell expansion and Th17 development. PLoS Pathog (2012) 1.18

Type I interferons directly inhibit regulatory T cells to allow optimal antiviral T cell responses during acute LCMV infection. J Exp Med (2014) 1.17

Defined conditions for development of functional hepatic cells from human embryonic stem cells. Stem Cells Dev (2005) 1.16

Deletion and anergy of polyclonal B cells specific for ubiquitous membrane-bound self-antigen. J Exp Med (2012) 1.15

Biomaterials for nanoparticle vaccine delivery systems. Pharm Res (2014) 1.09

Generation of effector memory T cell-based mucosal and systemic immunity with pulmonary nanoparticle vaccination. Sci Transl Med (2013) 1.09

Positive selection optimizes the number and function of MHCII-restricted CD4+ T cell clones in the naive polyclonal repertoire. Proc Natl Acad Sci U S A (2009) 1.09

In vivo assessment of the relative contributions of deletion, anergy, and editing to B cell self-tolerance. J Immunol (2005) 1.08

CD4+ memory T cell survival. Curr Opin Immunol (2011) 1.07

Primary induction of CD4 T cell responses in nasal associated lymphoid tissue during group A streptococcal infection. Eur J Immunol (2004) 1.07

Virulence of Toxoplasma gondii is associated with distinct dendritic cell responses and reduced numbers of activated CD8+ T cells. J Immunol (2010) 1.07

EphrinA I-targeted nanoshells for photothermal ablation of prostate cancer cells. Int J Nanomedicine (2008) 1.06

CD4+ T cell persistence and function after infection are maintained by low-level peptide:MHC class II presentation. J Immunol (2013) 1.05

Robust IgG responses to nanograms of antigen using a biomimetic lipid-coated particle vaccine. J Control Release (2011) 1.05

PD-1, but not PD-L1, expressed by islet-reactive CD4+ T cells suppresses infiltration of the pancreas during type 1 diabetes. Diabetes (2013) 1.04

CCR6-dependent recruitment of blood phagocytes is necessary for rapid CD4 T cell responses to local bacterial infection. Proc Natl Acad Sci U S A (2007) 1.01

Cutting edge: type 1 diabetes occurs despite robust anergy among endogenous insulin-specific CD4 T cells in NOD mice. J Immunol (2013) 1.00

Comprehensive analysis of antibody responses to streptococcal and tissue antigens in patients with acute rheumatic fever. Int Immunol (2008) 0.99

Cytosolic delivery mediated via electrostatic surface binding of protein, virus, or siRNA cargos to pH-responsive core-shell gel particles. Biomacromolecules (2009) 0.98

Proliferating CD4+ T cells undergo immediate growth arrest upon cessation of TCR signaling in vivo. J Immunol (2008) 0.97

Developmental alterations in thymocyte sensitivity are actively regulated by MHC class II expression in the thymic medulla. J Immunol (2006) 0.97

Releasable layer-by-layer assembly of stabilized lipid nanocapsules on microneedles for enhanced transcutaneous vaccine delivery. ACS Nano (2012) 0.93

Indirect minor histocompatibility antigen presentation by allograft recipient cells in the draining lymph node leads to the activation and clonal expansion of CD4+ T cells that cause obliterative airways disease. J Immunol (2004) 0.93

Streptococcal modulation of cellular invasion via TGF-beta1 signaling. Proc Natl Acad Sci U S A (2006) 0.90

Uncoupling of promitogenic and antiapoptotic functions of IL-2 by Smad-dependent TGF-beta signaling. J Immunol (2003) 0.89

Tracking antigen-specific CD4+ T cells throughout the course of chronic Leishmania major infection in resistant mice. Eur J Immunol (2012) 0.89

The transcription factors Thpok and LRF are necessary and partly redundant for T helper cell differentiation. Immunity (2012) 0.88

A protease-dependent mechanism for initiating T-dependent B cell responses to large particulate antigens. J Immunol (2010) 0.88

High-Density Lipoproteins: Nature's Multifunctional Nanoparticles. ACS Nano (2016) 0.87

CD25+Foxp3+ regulatory T cells facilitate CD4+ T cell clonal anergy induction during the recovery from lymphopenia. J Immunol (2006) 0.87

Antigen persistence is required for dendritic cell licensing and CD8+ T cell cross-priming. J Immunol (2008) 0.87

Peptide:MHC tetramer-based enrichment of epitope-specific T cells. J Vis Exp (2012) 0.87

CD4+ T Cells: guardians of the phagosome. Clin Microbiol Rev (2014) 0.87